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Objective: To determine the effectiveness of physiotherapy plus conventional treatment (CT) 
compared to CT alone for the treatment of functional constipation (FC) in children aged 4–17 years 
in primary care. 
Methods: Pragmatic randomized controlled trial with 8 months follow-up. Primary care physicians 
recruited children diagnosed with FC (n=234), and pediatricians recruited newly referred children 
with a diagnosis of FC (n=11). CT comprised toilet training, nutritional advice, and laxative 
prescribing, whereas physiotherapy focused on resolving dyssynergic defecation. The primary 
outcome was treatment success over 8 months, defined as the absence of FC (Rome III criteria) 
without laxative use. Secondary outcomes included the absence of FC irrespective of continuation of 
laxative use and global perceived treatment effect.  
Results: Children were allocated to CT plus physiotherapy or CT alone (67 per group), mean (SD) age 
was 7.6 (3.5) years. Results of longitudinal analyses in the intention-to-treat population showed that 
the treatment success percentage was not statistically improved by adding physiotherapy to CT (aRR 
0.80, 95%CI 0.44–1.30). At 4 months, fewer children receiving physiotherapy had treatment success 
(17%) than children receiving CT alone (28%), but this had equalized by 8 months (42% and 41%, 
respectively). The percentage of children without FC, irrespective of continuation of laxative use, 
was not statistically different between groups over 8 months (aRR 1.12, 95%CI 0.82–1.34). Notably, 
parents reported significantly more global symptom improvement after physiotherapy than after CT 
(aRR 1.40; 95%CI 1.00–1.73).  
Conclusions: We find no evidence to recommend physiotherapy for all children with FC in primary 
care. 
Trial registration: Netherlands Trial Register (NTR4797), registered 8 September 2014. 
Abbreviations: CT, conventional treatment; FC, functional constipation; PCP, primary care physician; 
RR, relative risk; aRR, adjusted relative risk; CI, confidence interval; RCT, randomized controlled trial; 
QPGS-RIII, Questionnaire on Pediatric Gastrointestinal Symptoms Rome III; OR, odds ratio;  
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Background 
Childhood functional constipation (FC) is a common problem worldwide.1 It is characterized by 
bothersome and often embarrassing symptoms that include abdominal pain, painful bowel 
movements, large stools, and fecal incontinence.2, 3 Children with FC are more likely than their peers 
to suffer low self-esteem and bullying, which negatively affect their quality of life and that of their 
families.4-7 At present, the management of FC tackles its multifactorial nature, with focus on toilet 
training, dietary advice, reassurance, and education, but it is not evidence based.8, 9 Laxatives are 
also recommended as a first-line treatment but the quality of evidence on the effectiveness of 
laxatives is low and adherence to the advised dosage is problematic.8, 10-12 The lack of evidence for 
either of these options risks heterogeneous management and inadequate therapeutic responses.3 
Indeed, it has been reported that 50% of children with FC have persistent symptoms after 6–12 
months of conventional treatment (CT) and that 25% have symptoms that persist into adulthood.13, 
14 Predicting which children will profit from treatment is difficult, as the evidence regarding 
prognostic factors is inconsistent.8, 14 
The pathophysiology underlying FC is poorly understood, but it is thought that many children have 
dyssynergic defecation.15, 16 This refers to a dysfunction in the interaction between pelvic floor and 
abdominal muscles, where a failure to obtain appropriate intra-abdominal pressure during bowel 
movements is compounded by paradoxical contraction of the pelvic floor.16-19 Two small randomized 
controlled trials in secondary and tertiary care have shown some positive effects when specialist 
physiotherapists offered pelvic floor and abdominal muscle training to resolve this dyssynergy.20, 21 
Given that FC is associated with increased medical costs,22, 23 physiotherapy in an early stage, when 
effective, could prevent relapses and reduce referrals to secondary care, thereby reducing costs. 
In this pragmatic randomized controlled trial (RCT), we aimed to determine the effectiveness of 
physiotherapy plus CT compared to CT alone over 8-month follow-up period for the treatment of FC 




The design of this pragmatic RCT has been published in detail elsewhere.24 This was approved by the 
Medical Ethical Board of the University Medical Center of Groningen (METC2013/331) and was 
registered in the Netherlands Trial Register (NTR4797). Parents of all children, and children 
themselves when aged ≥12 years, provided written informed consent. 
Participants 
Children aged 4–17 years diagnosed with FC by their primary care physician (PCP) were considered 
eligible for participation. Between September 2014 and March 2017, participating PCPs (n = 209) 
recruited consecutive children presenting with FC (incident cases PCP), while general pediatricians 
from five outpatient departments in the north of the Netherlands recruited consecutive children 
who were newly referred with a diagnosis of FC (incident cases pediatrician) (Figure 1). Any child 
who had consulted a PCP for FC in the preceding 12 months also received a leaflet explaining the 
study, plus a short questionnaire to assess eligibility (e.g., presence of FC symptoms or laxative use 
in the preceding 4 weeks) (prevalent cases PCP). We excluded children with psychopathology that 
could affect protocol adherence, those with severe or terminal illness (physician determined), and 
those who had received physiotherapy or urotherapy for constipation within the past 3 years. 
Randomization, stratification, and blinding 
Eligible children were randomly allocated in a 1:1 ratio to one of two treatment groups, using a 
computer-generated randomization list with random block sizes. The list was maintained by a 
researcher who was not involved in the study and had no access to the allocation site. Group 
randomization was stratified by age (4–8 years and 9–17 years). The allocation sequence was 
concealed from the researcher who assigned participants to the study groups. As we did a pragmatic 
trial we did not blind practitioners and participants to group allocation, but we did blind 




Children in the control group received CT only, which involved education, dietary advice, toilet 
training, and laxative prescribing according to Dutch guidelines for the management of FC.27 These 
are comparable to international guidelines.8 No restrictions or specific instructions were given to 
physicians regarding CT. 
Children in the intervention group received CT plus physiotherapy that was carried out by specialist 
physiotherapists (i.e., with a master’s degree in pediatric or pelvic physiotherapy and certified after 
additional postgraduate training in the treatment of bladder and bowel dysfunction in children). 
These primary care physiotherapists are readily accessible in the Netherlands. A structured 
physiotherapy program was developed that had six defecation-related goals: 1) improving 
knowledge about defecation and the role of the child and/or parent in symptom persistence; 2) 
improving toilet behavior and posture; 3) increasing awareness of the sensation of needing to 
defecate; 4) learning to relax while defecating; 5) learning to generate adequate intra-abdominal 
pressure during defecation; and 6) teaching effective straining during defecation.24 Programs were 
tailored to each patient and delivered in a manner appropriate to his or her developmental age and 
locomotor skills, allowing a maximum of nine half-hour sessions. Physiotherapy was ended earlier if 
the physiotherapist considered that treatment was successful or that no further improvement was 
expected. 
Outcome measurements 
The primary outcome was the difference in treatment success over time between the intervention 
and control groups. Treatment success was defined as meeting no more than one of the six Rome III 
criteria, with no laxative use for 4 weeks before measurement (absence of FC without laxative use).28 
Rome III criteria were assessed with the standardized Questionnaire on Pediatric Gastrointestinal 
Symptoms Rome III (QPGS-RIII), adapted to evaluate symptoms over 4 weeks instead of 2 months, 
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consistent with the new Rome IV criteria.29 The questionnaire was completed by parents (for 
children aged 4–12 years) or children themselves (if aged 13–17 years). In all cases, parents 
answered the question “Did your child use laxatives in the past four weeks?” (yes or no). 
The main secondary outcome was treatment success over time, as defined for the primary outcome, 
but irrespective of recent laxative use. Quality of life was measured by asking parents to complete 
the emotional and social functioning subdomains of the defecation disorder list,30, 31 which have 
good internal consistency and construct validity.31, 32 Finally, the global perceived effect of treatment 
was evaluated with the question “To what extent are the child’s symptoms changed compared to 
the start of the study?” that was scored on a 9-point Likert-type scale.33 Treatment was considered 
effective when parents reported their child to be very much or much improved. 
All outcomes were measured at baseline and at 4 and 8 months thereafter. Other baseline data 
included age, sex, duration of symptoms, and chronic laxative use (defined as continuous or 
intermittent laxative use in the 12 months before inclusion). 
Statistical analyses 
The sample size was estimated at 128 children based on an expected treatment success of 50% in 
the control group after 8 months,14 with physiotherapy hypothesized to improve success by an 
additional 25% (10% loss to follow-up, alpha 0.05, power 0.80).20, 24, 34  
We performed multilevel analysis of our longitudinal data using MLwiN 3.01 (Centre for Multilevel 
Modelling, University of Bristol, UK). The first and second levels were the time of measurement and 
the patient, respectively. An iterative generalized least squares algorithm was used to estimate the 
regression coefficients, and the Wald test was set to obtain P-values for each coefficient. To 
facilitate interpretation, we converted each OR to a relative risk (RR), as follows: RR = OR / [1 + 
Control Event Rate (OR − 1)].35 
Logistic and linear multilevel analyses were used to investigate the differences between study 
groups over time. Analyses were adjusted for clinically relevant baseline differences. We did not 
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impute missing data because this is considered redundant in longitudinal datasets.36 We based the 
primary analyses on an intention-to-treat population and set the significance level at a two-sided P-
value of <0.05. A secondary per-protocol analysis was conducted for the primary and the secondary 
outcomes of treatment success. The intention-to-treat population included all patients who 
provided informed consent and were randomly allocated to a treatment group, irrespective of 
whether they received that treatment. The per-protocol population comprised patients who 
completed the assigned interventions and assessments.37 Propensity scores were used if imbalances 
occurred in the per-protocol population.37 A preplanned subgroup analysis was performed to 
evaluate whether the effect of the intervention was different for children with and without chronic 
laxative use at baseline.  
Finally, in a univariate logistic regression analyses, predictors for treatment success after 8 months 
were identified in the whole study population out of a preselected set of baseline clinical symptoms 






Figure 1 summarizes the participant flow for 134 children randomly assigned to the study groups. 
Among all recruiting physicians, 71 GPs and pediatricians in 3 district hospitals actually included at 
least one patient to the study. Patient characteristics are shown in Table 1. Although clinically 
relevant differences existed for symptom duration and chronic laxative use, we only adjusted for 
chronic laxative use because the variables correlated. Drop-out rates at 4 and 8 months were 16% 
and 24%, respectively; the baseline features of drop-outs were comparable to those of completers. 
In the CT group, 6 children were referred to a physiotherapist due to symptom persistence, and in 
the intervention group, 6 children did not receive physiotherapy (Figure 1). Participants who 
completed physiotherapy had an average of 5.4 (SD 2.7) sessions with a median of 98 days 
(interquartile range 63–145 days) between the first and last sessions. 
Intention-to-treat analyses 
In total, 115 participants completed at least one of the two follow-up measurements and were 
included in the intention-to-treat analyses (Figure 1). Table 2 shows the percentage of successfully 
treated children after 4 and 8 months and the corresponding overall RRs. Over 8 months, success 
rates (absence of FC and no laxative use) were not significantly different between intervention and 
control group (aRR 0.80, 95%CI 0.44–1.30). At 4 months, fewer children receiving physiotherapy 
(17%) had treatment success than children receiving CT alone (28%), but this had equalized by 8 
months (42% and 41%). 
When treatment success was defined as absence of FC irrespective of continuation of laxatives there 
remained no significant differences between intervention and control group (aRR 1.12, 95%CI 0.82–
1.34). However, while success rates were comparable at 4 months (68% and 64%), at 8 months the 
success rate was slightly higher in children receiving physiotherapy (73%) than in children receiving 
CT (61%). Regarding the other secondary outcomes, no longitudinal difference was found for quality 
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of life between treatment groups (Table 2). A significant difference existed in the global perceived 
treatment effect between the groups, favoring the physiotherapy group (aRR 1.40, 95%CI 1.00–
1.73). 
Per protocol analyses 
At baseline, there were no imbalances in patient characteristics for the per-protocol population (n = 
107). Analyses revealed no significant differences over time between intervention and control group 
when success was defined as the absence of FC either without laxatives (aRR 0.88, 95%CI 0.60–1.13) 
or irrespective of laxative use (aRR 0.98, 95%CI 0.53–1.56). 
Subgroup analyses 
Table 3 (online) shows the baseline characteristics of the subgroups of children with (n = 72) and 
without (n = 43) chronic laxative use. Table 4 (online) shows the percentage of successfully treated 
children per subgroup after 4 and 8 months, with the corresponding RRs for the entire period. In 
children with chronic laxative use, we observed only a significant difference between the 
intervention and control group for the main secondary outcome, absence of FC irrespective of 
continuation of laxative use, (RR 1.40, 95%CI 1.00–1.63). In children without chronic laxative use, we 
did not observe any significant differences over time between treatment groups. 
Prognostic factors for treatment success after 8 months 
Stool withholding, fecal incontinence and abdominal pain were in the univariate analyses, 





During the study period, we found no benefit from adding physiotherapy to CT in terms of either 
treatment success or quality of life. By contrast, parents in the physiotherapy group did report 
symptom improvement significantly more often compared with the CT group. A potential 
explanation for this  discrepancy between outcomes is that parents of children receiving 
physiotherapy may have been more willing to report improvements because of the additional 
attention. However, it is also possible that parents valued improvements in symptoms not included 
in the Rome criteria. For example, abdominal pain is not considered in these criteria, but a recent 
study indicated that parents and children both felt that change in abdominal pain was an important 
treatment outcome.38 
Comparisons with other studies 
The effectiveness of physiotherapy in childhood FC was previously measured in two studies in 
district (n = 53)20 and university (n = 72)21 hospitals. Neither study defined treatment success as the 
absence of FC without laxative use, but one did evaluate the effectiveness of physiotherapy as the 
absence of FC irrespective of laxative use.20 Defined in this way, the treatment success rate in the CT 
group was comparable between both studies, and similar to others,14 but the beneficial effect of 
adding physiotherapy differed. We found no difference in effect between physiotherapy and CT over 
8 months (OR 1.3, 95%CI 0.6–3.1), whereas a significant difference was found in the hospital study at 
6 months (OR 11.7, 95%CI 1.8 to 78.3). Children with chronic laxative use may be overrepresented in 
district hospitals. In our subgroup of children with chronic laxative use we observed a significant 
difference in effect between the physiotherapy and CT groups (OR 2.7, 95%CI 1.0 to 7.4), though to a 
much smaller extent than in the hospital study. The effect size in the hospital study might have been 
exaggerated or due to a type I error given the wide confidence interval and small sample size.34 
Other explanations for the observed differences in the added value of physiotherapy could be the 
heterogeneity in physiotherapy interventions and follow-up time. The outcomes measured in the 
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university hospital study were not comparable to those used in our study.21 
Outcomes in clinical trials of children with FC have varied greatly.40 To enhance comparison of 
results between studies, experts recently agreed to use treatment success as a primary outcome in 
clinical trials, with success simply defined as no longer meeting Rome criteria for FC.41 Our primary 
outcome used a stricter definition of success that required no laxative use in the previous 4 weeks. 
Nevertheless, the definition used for our main secondary outcome was consistent with the expert 
recommendation. It was therefore unsurprising that observed treatment success rates were lower 
when using our strict definition. The latest guidelines also recommend using a diary to monitor FC,41 
but we only used a validated self-administered questionnaires to minimize the burden of the study.28 
As a consequence, information about the number of bowel movements, episodes of fecal 
incontinence, and daily laxative dose may be less accurate. 
Strengths and weaknesses of this study 
Strengths of our study include the relatively large sample size and the pragmatic design.25, 26 This 
design meant that practitioners and participants were not blinded and we could include the effect of 
the patient–caregiver relationship. In addition, the participation of a large number of practitioners 
who were given the flexibility to adjust treatment intensity in both interventions ensures that our 
results are generalizable to routine practice in the Netherlands. Despite these strengths, there are 
some limitations. Notably, only 60% of the eligible children were included, and 24% of these did not 
complete all follow-up measurements. Children who refused to participate tended to be older and to 
have less chronic laxative use compared with participants.24 This means that the results of this study 
are less generalizable to older children and to children who recently started using laxatives. To 
minimize the influence of drop-outs and to consider the fluctuating natural course of FC, we used 
longitudinal analysis in the intention-to-treat population. Also, given that research has shown that 
17%–41% of children relapse within the first year after treatment success, and given that 50%–60% 
relapse within 5 years,39 our follow-up time of 8 months was too short to make definitive statements 
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on the long-term preventive effect of physiotherapy on relapses. Another limitation is that we did 
not evaluate the effects of the different elements of the physiotherapy program. We have chosen 
patient relevant outcome measures and we did not assess pelvic floor muscle (dys)synergia, as we 
considered this too invasive for children. Finally, our sample size was too small to perform 
multivariate analysis to identify prognostic factors that were independently related to treatment 
success after 8 months, but we recommend for future research to take into account stool 
withholding, fecal incontinence and abdominal pain as potential prognostic factors. 
Implications for clinicians and researchers 
Our findings mean that we must reject our hypothesis that physiotherapy is most effective in the 
early stages of FC. However, physiotherapy in primary care might be effective for children with 
protracted symptoms. Children with early stages of FC and their parents are possibly insufficiently 
motivated to invest time in a physiotherapy treatment. This was also observed as the most 
important reason for children and their parents not to participate in the study.24 Non-adherence has 
also been described with laxative treatment.11 More research is needed to determine whether 
physiotherapy can be beneficial in primary care when started at a later stage of FC, when symptoms 
have become more chronic and children and parents are more motivated, and whether the effect of 
physiotherapy can be predicted by patient factors or psychosocial circumstances related to onset.  
Conclusions 
In conclusion, we found no objective benefit from adding physiotherapy to CT for the whole group of 
children with FC consulting in primary care, although parents were more satisfied with 
physiotherapy. More research is needed to evaluate whether physiotherapy in primary care is both 
effective and cost-effective for children with symptoms of longer duration. 
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Figure 1. Flowchart of participant recruitment and participant flow through the study.  
Abbreviations: FC, functional constipation; PCP, Primary Care Physician. Reasons for not receiving 
physiotherapy in the physio group were: time constraints of parents/children (n = 2), symptom 
resolution by the time of the physiotherapy appointment (n = 1), and cancelling the appointment 
without a reason (n = 3).  
a In the physio group the number of analyzed children in the per protocol analysis at 4 months was 
56 because three children did not receive physiotherapy and were lost to follow-up. 
b In the conventional treatment group the number of analyzed children in the per protocol analysis 
at 8 months follow-up was 44 because two children did receive physiotherapy after 4 months and 












- Aged 4 to 18 years
- Diagnosis of FC by their GP or pediatrician 
Randomized (n=134)
Exclusion (n=90)
- Not interested / symptoms under control (n=65)
- Physiotherapy or urotherapy for constipation in the past 3 years (n=9)
- Preference for treatment group (n=7)  
- No informed consent second parent (n=4)
- Insufficient command of Dutch language to fill in questionnaires (n=3)
- Inappropriate for study because of family circumstances (n=2)
Allocated to conventional treatment (n=67)
Received conventional treatment (n=61)
 
Started physiotherapy before 4 months (n=2)




Did not receive physiotherapy (n=6)
No follow up measurement at
4 and 8 months (n=6)  
4 months (n=2)
8 months (n=7)
Analysed in intention to treat analyses (n=61)
4 months (n=59) 
8 months (n=53)
Analysed in per protocol analyses (n=56)
4 months (n=56)a  
8 months (n=49)
No follow up measurement at
4 and 8 months (n=13)
4 months (n=1)
8 months (n=5)
Analysed in intention to treat analyses (n=54)
4 months (n=53) 
8 months (n=49)




Table 1. Baseline characteristics (n = 134) 
 Physio (n = 67) CT (n = 67) 
Age (years), mean ± standard deviation 7.3 ± 3.4 7.8 ± 3.5 
Girls n (%) 38/67 (57%) 44/67 (66%) 
Duration of symptoms n (%)   
≤3 months 4/58 (7%) 12/62 (19%) 
3–12 months 6/58 (10%) 10/62 (16%) 
>12 months 48/58 (83%) 40/62 (65%) 
Chronic laxative use a n (%) 41/57 (72%) 31/58 (53%) 
Previous episodes of FC n (%)   
≥ 2  43/61 (71%) 42/64 (66%) 
1 4/61 (7%) 3/64 (5%) 
0 14/61 (21%) 19/64 (30%) 
Use of laxatives in previous 4 weeks n (%) 46/56 (82%) 44/59 (75%) 
Abdominal pain/discomfort ≥ once a week n (%) 35/66 (53%) 41/67 (61%) 
Constipation-related symptoms and signs (Rome III criteria) 
≤2 defecations in the toilet per week n (%) 16/67 (24%) 10/67 (15%) 
Fecal incontinence ≥1 per week n (%) 26/67 (39%) 34/67 (50%) 
Stool withholding n (%) 22/67 (33%) 18/67 (27%) 
Painful or hard bowel movements n (%) 51/67 (76%) 46/51 (69%) 
Large fecal mass in the abdomen or rectum n (%) 36/67 (54%) 38/67 (57%) 
Large stools that obstruct the toilet n (%) 11/67 (16%) 12/67 (18%) 
Abbreviations: CT, conventional treatment; FC, functional constipation; Physio, physiotherapy. 
a Chronic laxative use was defined as continuous or regular laxative use (≥3 periods) in the 12 months 
before inclusion. 
Table 2. Intention-to-treat analysis of the primary and secondary outcomes after 4 and 8 months, with the (a)RR over 8 months  
 4 months 8 months    
 Physio CT Physio CT RR /β (95%CI) aRR/β (95%CI)a p 
Total group, N 59 53 53  49    
Absence of FC, laxatives not allowed n (%) 10/58 (17%) 14/51 (28%) 22/53 (42%) 20/49 (41%) 0.85 (0.49–1.32) 0.80 (0.44–1.30) 0.397 
Absence of FC, laxatives allowed n (%) 40/59 (68%) 34/53 (64%) 38/52 (73%) 30/49 (61%) 1.12 (0.85–1.32) 1.12 (0.82–1.34) 0.405 
Quality of life median (IQR) 82 (75–88) 84 (74–88) 85 (79–92) 85 (77–90) β: 0.1 (-4.0 to 4.3) β : -0.9 (-5.2 to 3.4) 0.675 
Global perceived effect n (%) 36/57 (63%) 19/50 (38%) 33/53 (62%) 25/48 (52%) 1.39* (1.03–1.70) 1.40* (1.00–1.73) 0.048* 
Abbreviations: (a)RR, (adjusted) relative risk; β, beta coefficient; CT, conventional treatment; Physio, physiotherapy. 
a Adjusted for chronic laxative use. * p < 0.05 
 
Table S1. Baseline characteristics of children with and without chronic laxative use 
 
Children with chronic laxative use 
(n = 72) a 
Children without chronic laxative use 
(n = 43) a 
 Physio (n = 41) CT (n = 31) Physio (n = 16) CT (n = 27) 
Age (in years) Mean (SD) 7.29 (3.47) 7.55 (3.82) 7.44 (3.89) 8.00 (3.21) 
Girls n (%) 25/41 (61%) 25/31 (81%) 8/16 (50%) 14/27 (52%) 
Use of laxatives in previous 4 weeks n (%) 35/41 (85%) 26/31 (84%) 11/15 (69%) 17/27 (63%) 
Abdominal pain/discomfort ≥ once a week n (%) 19/41 (48%) 17/31 (55%) 10/16 (63%) 18/27 (67%) 
Constipation-related symptoms and signs (Rome III criteria)     
≤2 defecations in the toilet per week n (%) 8/41 (20%) 3/31 (10%) 5/16 (31%) 5/27 (19%) 
Fecal incontinence ≥1 per week n (%) 12/41 (29%) 16/31 (52%) 8/16 (50%) 14/27 (52%) 
Stool withholding n (%) 10/41 (24%) 8/31 (26%) 6/16 (38%) 8/27 (30%) 
Painful or hard bowel movements n (%) 29/41 (71%) 19/31 (61%) 12/16 (75%) 20/27 (74%) 
Large fecal mass in the abdomen or rectum n (%) 23/41 (56%) 20/31 (65%) 8/16 (50%) 12/27 (44%) 
Large stools that obstruct the toilet n (%) 6/41 (15%) 6/31 (19%) 2/16 (13%) 5/27 (19%) 
Abbreviations: CT, conventional treatment; Physio, physiotherapy. 
a chronic laxative use was not known for 19 children. 
Table S2. Intention-to-treat analysis of outcomes after 4 and 8 months by chronic laxative use, with the RR over 8 months 
 4 months 8 months   
 Physio CT Physio CT RR or β (95%CI) p 
Children with chronic laxative use  N = 39 N = 26 n = 31 n = 21   
Absence of FC without the use of laxatives n (%) 8/39 (21%) 6/26 (23%) 15/31 (48%) 8/21 (38%) 1.01 (0.52–1.90) 0.783 
Absence of FC with or without laxatives n (%) 28/38 (74%) 16/26 (62%) 25/30 (83%) 10/21 (48%) 1.40* (1.00–1.63) 0.049 
Quality of life median (IQR) 82 (76–88) 87 (77–92) 87 (81–92) 88 (82–92) β: 0.5 (-4.7 to 5.7) 0.850 
Global perceived effect n (%) 23/39 (59%) 8/25 (32%) 19/31 (61%) 10/20 (50%) 1.51 (0.96–1.96) 0.069 
Children without chronic laxative use N = 14 N = 18 N = 15 N = 19   
Absence of FC without the use of laxatives n (%) 1/14 (7%) 7/18 (39%) 5/15 (33%) 10/19 (53%) 0.46 (0.15–1.04) 0.066 
Absence of FC irrespective laxative use n (%) 7/14 (50%) 13/18 (72%) 9/15 (60%) 14/19 (74%) 0.77 (0.35–1.12) 0.259 
Quality of life median, (IQR) 78 (63–87) 83 (68–87) 80 (63–86) 82 (69–88) β: -3.5 (-11.1 to 4.2) 0.374 
Global perceived effect n (%) 8/13 (62%) 9/18 (50%) 10/15 (67%) 10/19 (53%) 1.25 (0.69–1.67) 0.382 
Abbreviations: β, beta coefficient; CT, conventional treatment; Physio, physiotherapy; RR, relative risk. 
* p < 0.05 
 
 
Table S3. Distribution of candidate predictors in relation to two definitions of treatment success in the whole study population after 8 months (results of 
univariate logistic regression analyses).  
 Model 1  Model 2  
 Absence of 
FC and no 
laxatives 
(n=42) 
Presence of FC 

















Abdominal pain, ≥1 
weekly (n, %)  
19/42 (45) 37/59 (62) 0.5 
(0.2-1.1) 






0/42 (0) 6/59 (10) 0.8 
(0.3-2.5) 




≥1 weekly (n,%)  
1/42 (2) 24/59 (41) 0.5  
(0.2-1.1) 
0.082 0.041 4/68 (6) 21/33 (64) 0.2 
(0.1-0.5) 
0.000 0.178 
Painful or hard 
bowel movements 
(n,%) 
8/42 (19) 29/59 (49) 0.9 
(0.4-2.2) 





0/42 (0) 15/59 (25) 0.3 
(0.1-0.8) 
0.012 0.090 1/68 (1) 14/33 (42) 0.2 
(0.1-0.4) 
0.000 0.207 
Large stools that 
obstruct the toilet 
(n,%) 
1/42 (2) 9/59 (15) 0.7 
(0.2-2.2) 
0.565 0.004 3/68 (4) 7/33 (21) 0.9 
(0.3-2.6) 
0.801 0.001 
           
In model 1 treatment success is defined as absence of functional constipation according the Rome III criteria and no laxative use. In model 2 the treatment 
success is defined as absence of functional constipation according to the Rome III criteria irrespective of laxative use. 
b The candidate predictor chronic laxative use has 16 missing values. 
